Biotech News
UroGen Pharma to Present at the TD Cowen 46th Annual Health Care Conference
investors.urogen.com2026-05-06 15:01 EST
PRINCETON, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that management will present at the TD Cowen 46th Annual Health Care